Risperdal Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Latest Verdict in Gynecomastia Bellwether Trial

November 10, 2015 - A Pennsylvania jury has awarded $1.8 million to a Risperdal lawsuit (http://www.rxinjuryhelp.com/risperdal/lawsuit/) plaintiff who developed gynecomastia as a result of treatment with the atypical antipsychotic medication. According to a verdict rendered in the Philadelphia Court of Common Pleas on November 9th, jurors found that Johnson & Johnson and its Janssen Pharmaceuticals unit had failed to provide adequate warnings to doctors and patients regarding the medication's association with excessive male breast growth. The plaintiff, who had been prescribed Risperdal off-label when he was 9-years-old to alleviate symptoms associated with autism, was awarded compensatory damages for disfigurement and mental anguish. (Case No. 130401990)

"This is the second time a Pennsylvania jury has found in favor of a Risperdal gynecomastia plaintiff this year. Our Firm is representing a number of Risperdal clients who are alleged to have experienced similar complications, and we are very pleased with the outcome in this case," said Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to provide free Risperdal lawsuit reviews to individuals who allegedly developed gynecomastia as a result of treatment with the medication.

Risperdal Litigation
Risperdal is an atypical antipsychotic medication that was initially approved by the U.S. Food & Drug Administration (FDA) in 1993 to treat adults with schizophrenia. Its approved uses were eventually expanded to include bipolar disorder in adults and adolescents, as well as irritability experienced by autistic children. The medication was not cleared for any pediatric indications until 2006, three years after the plaintiff in this case began using Risperdal for autism.

The Philadelphia Court of Common Pleas is currently the venue for a Risperdal mass tort litigation that houses more than 1,500 product liability lawsuits, all of which were filed on behalf of plaintiffs who allegedly experienced gynecomastia and other serious complications related to the medication. The just-concluded trial was considered a bellwether case, and was intended to provide insight into how juries might rule in similar lawsuits involving Risperdal and male breast growth.

Court records indicate that two other Risperdal gynecomastia trials concluded in the Pennsylvania litigation earlier this year. The first verdict was rendered in February, when the jury hearing that case awarded $2.6 million to another plaintiff who had also been prescribed Risperdal off-label for autism. (Case No. A-196444) A second case was heard the following month, with the jury finding that Johnson & Johnson and Janssen's warnings regarding male breast growth were inadequate. However, jurors declined to award the plaintiff any damages after determining that there was not enough evidence to conclude that the drug had caused his condition. (Case No. 130301803)

Alleged victims of Risperdal and gynecomastia may be eligible to join the litigation involving this medication. To learn more about filing a Risperdal lawsuit, please contact Bernstein Liebhard LLP for a free case review by visiting the Firm's website, or by calling 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. The Firm was named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list for a dozen consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
info (at) consumerinjurylawyers (dot) com
http://www.rxinjuryhelp.com/
https://plus.google.com/115936073311125306742?rel=author